Alliance for NanoHealth Appoints New President
Dr. Mauro Ferrari has been named as the new President for the Alliance for NanoHealth
Dr. Mauro Ferrari is a founder of biomedical nano-/micro-technology, especially pertaining to drug delivery, cell transplantation, implantable bioreactors, and other innovative therapeutic modalities. In these fields, he has published approximately one hundred papers (typically in journals such as Nature, Biotechnology and Bioengineering, Journal of Applied Physics, Biomaterials, and others), and six (6) books (two more are in preparation). He is the inventor of more than 20 issued patents, with about thirty more pending in the US and internationally. His contributions have been recognized by a variety of accolades, including the Presidential Young Investigator Award of the National Science Foundation, a Shannon Director's Award of the National Institutes of Health, and the Wallace H. Coulter Award for Biomedical Innovation and Entrepreneurship. His career research and development portfolio totals over $30 million, including support from the NIH, NSF, DARPA, DoE, as well as the Board of Regents of the State of Ohio, The Ohio State University, and private enterprises such as Roche, Boehringer-Mannheim, Alcoa, Vion Pharmaceuticals, and iMEDD. He began his academic career at the University of California, Berkley, where he tenured in Material Science, Civil Engineering, and Bioengineering. Upon recruitment to the Ohio State University, he served as the Edgar Hendrickson Professor of Biomedical Engineering, Professor of Internal Medicine, Mechanical Engineering, Materials Science and Associate Vice President, Health Sciences Technology and Commercialization, Associate Director of the Dorothy M. Davis Heart and Lung Research Institute and Director of the Biomedical Engineering Center.
Dr. Ferrari also served as Special Expert on Nanotechnology at the National Cancer Institute in 2003-2005, providing leadership into the formulation, refinement, and approval of the NCI's Alliance for Nanotechnology in Cancer, currently the world's largest program in medical nanotechnology.
Currently, Dr. Ferrari serves as: Professor, Brown Institute of Molecular Medicine, Chairman, Department of Biomedical Engineering, University of Texas Health Science Center at Houston, Professor of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston TX., Professor of Bioengineering, Rice University, Houston TX., Professor of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston TX. and President, of the Alliance for NanoHealth, Houston TX.